These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 29587718)

  • 1. Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective study.
    He LY; Zhang M; Chen ZW; Yuan JL; Ye DW; Ma LL; Wei H; Yang JG; Chen S; Wan B; Xia SJ; Weng ZL; Kong XB; Wei Q; Jin FS; Zhang XH; Qian WQ; Wang SS; Chen YH; Ma HS; Sun YH; Gao X
    BMC Urol; 2018 Mar; 18(1):23. PubMed ID: 29587718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the beneficial effects of triptorelin on lower urinary tract symptoms in Algeria in patients with non-localized prostate cancer].
    Hachi K; Boualga K; Chettibi K; Harouni M; Ounnoughene M; Bekkat-Berkani N; Maisonobe P; Yousfi MJ
    Prog Urol; 2018 Jun; 28(8-9):450-459. PubMed ID: 29789236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.
    Gil T; Aoun F; Cabri P; Maisonobe P; van Velthoven R
    Ther Adv Urol; 2015 Jun; 7(3):116-24. PubMed ID: 26161142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of LHRH analogs on lower urinary tract symptoms associated with advanced prostate cancer in real clinical practice: ANALUTS study.
    Morote J; Gómez-Caamaño A; de Celis RP; Gómez-Veiga F; Ciria JP; Calleja J; Extramiana J; Pérez-Sampietro M; Perrot V; Angulo JC;
    Neurourol Urodyn; 2022 Nov; 41(8):1824-1833. PubMed ID: 36069170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degarelix Versus Goserelin Plus Bicalutamide in the Short-Term Relief of Lower Urinary Tract Symptoms in Prostate Cancer Patients: Results of a Pooled Analysis.
    Mason M; Richaud P; Bosnyak Z; Malmberg A; Neijber A
    Low Urin Tract Symptoms; 2017 May; 9(2):82-88. PubMed ID: 28394498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer.
    Washino S; Hirai M; Saito K; Kobayashi Y; Arai Y; Miyagawa T
    Low Urin Tract Symptoms; 2018 Jan; 10(1):57-63. PubMed ID: 27943566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of tamsulosin in the relief of lower urinary tract symptoms in advanced prostate cancer patients.
    Zhang T; Wu H; Liu S; He W; Ding K
    Int Urol Nephrol; 2017 Jul; 49(7):1111-1117. PubMed ID: 28409402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
    Gil T; Aoun F; Cabri P; Perrot V; van Velthoven R
    Ther Adv Urol; 2017 Jul; 9(7):179-190. PubMed ID: 28747996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
    Martínez-Piñeiro L; Schalken JA; Cabri P; Maisonobe P; de la Taille A;
    BJU Int; 2014 Oct; 114(4):608-16. PubMed ID: 24806330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of triptorelin on lower urinary tract symptoms in Australian prostate cancer patients.
    Woo HH; Murphy DG; Testa GM; Grummet JP; Chong M; Stork AP
    Res Rep Urol; 2017; 9():27-35. PubMed ID: 28261572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptorelin therapy for lower urinary tract symptoms (LUTS) in prostate cancer patients: A systematic meta-analysis.
    Barrett R; Birch B
    BJUI Compass; 2024 Jan; 5(1):17-28. PubMed ID: 38179030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower Urinary Tract Symptoms and Urinary Bother Are Common in Patients Undergoing Elective Cervical Spine Surgery.
    Lieberman EG; Radoslovich S; Marshall LM; Yoo JU
    Clin Orthop Relat Res; 2019 Apr; 477(4):872-878. PubMed ID: 30844824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50-69 years with PSA ≥3 ng/ml.
    Chandra Engel J; Palsdottir T; Aly M; Egevad L; Grönberg H; Eklund M; Nordström T
    Scand J Urol; 2020 Feb; 54(1):1-6. PubMed ID: 31876229
    [No Abstract]   [Full Text] [Related]  

  • 17. Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: results from a phase IIIb study (NCT00831233).
    Anderson J; Al-Ali G; Wirth M; Gual JB; Gomez Veiga F; Colli E; van der Meulen E; Persson BE
    Urol Int; 2013; 90(3):321-8. PubMed ID: 23258223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and severity of lower urinary tract symptoms are inversely correlated with the risk of prostate cancer on prostate biopsy.
    Cicione A; Cormio L; Cantiello F; Palumbo IM; DE Nunzio C; Lima E; Ucciero G; Carrieri G; Damiano R
    Minerva Urol Nefrol; 2017 Oct; 69(5):486-492. PubMed ID: 28124868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moving towards a comprehensive assessment of lower urinary tract symptoms (LUTS).
    Coyne KS; Barsdorf AI; Thompson C; Ireland A; Milsom I; Chapple C; Kopp ZS; Bavendam T
    Neurourol Urodyn; 2012 Apr; 31(4):448-54. PubMed ID: 22396308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone? : A prospective, randomized, controlled trial.
    Yan M; Xue P; Wang K; Gao G; Zhang W; Sun F
    Strahlenther Onkol; 2017 Sep; 193(9):714-721. PubMed ID: 28612083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.